BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Secades JJ. Role of Citicoline in the Management of Traumatic Brain Injury. Pharmaceuticals (Basel) 2021;14:410. [PMID: 33926011 DOI: 10.3390/ph14050410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Trimmel H, Herzer G, Derdak C, Kettenbach J, Grgac I. A novel pharmacological treatment concept for neuroprotection in severe traumatic brain injury—Two case reports. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6626] [Reference Citation Analysis]
2 Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE. Citicoline and COVID-19: vis-à-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 36063198 DOI: 10.1007/s00210-022-02284-6] [Reference Citation Analysis]
3 Javaid S, Farooq T, Rehman Z, Afzal A, Ashraf W, Rasool MF, Alqahtani F, Alsanea S, Alasmari F, Alanazi MM, Alharbi M, Imran I. Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities. Int J Mol Sci 2021;22:11313. [PMID: 34768742 DOI: 10.3390/ijms222111313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]